ArriVent BioPharma Inc

For the period ended Dec 31, 2024. Filed Mar 3, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 3, 2025

AVBP$13.64+11.5%Stored close · as of Nov 6, 2026

Opening this filing…